Ruszniewski P - Search Results

1

Ki67 proliferation index, hepatic tumor load, and pretreatment tumor growth predict the antitumoral efficacy of lanreotide in patients with malignant digestive neuroendocrine tumors.

Palazzo M, Lombard-Bohas C, Cadiot G, Matysiak-Budnik T, Rebours V, Vullierme MP, Couvelard A, Hentic O, Ruszniewski P. Palazzo M, et al. Among authors: ruszniewski p. Eur J Gastroenterol Hepatol. 2013 Feb;25(2):232-8. doi: 10.1097/MEG.0b013e328359d1a6. Eur J Gastroenterol Hepatol. 2013. PMID: 23108416

2

Influence of multiple endocrine neoplasia type 1 on gastric endocrine cells in patients with the Zollinger-Ellison syndrome.

Lehy T, Cadiot G, Mignon M, Ruszniewski P, Bonfils S. Lehy T, et al. Among authors: ruszniewski p. Gut. 1992 Sep;33(9):1275-9. doi: 10.1136/gut.33.9.1275. Gut. 1992. PMID: 1358767 Free PMC article.

3

[Long-term efficacy and tolerability of omeprazole in 20 patients with severe Zollinger-Ellison syndrome].

Cadranel JF, Ruszniewski P, Elouaer-Blanc L, Lehy T, Delchier JC, Cadiot G, Florent C, Vatier J, Mignon M. Cadranel JF, et al. Among authors: ruszniewski p. Gastroenterol Clin Biol. 1989 Aug-Sep;13(8-9):654-62. Gastroenterol Clin Biol. 1989. PMID: 2806801 French.

4

Gastric endocrine cell behavior in Zollinger-Ellison patients upon long-term potent antisecretory treatment.

Lehy T, Mignon M, Cadiot G, Elouaer-Blanc L, Ruszniewski P, Lewin MJ, Bonfils S. Lehy T, et al. Among authors: ruszniewski p. Gastroenterology. 1989 Apr;96(4):1029-40. doi: 10.1016/0016-5085(89)91620-x. Gastroenterology. 1989. PMID: 2925050

5

Clinical, anatomical, and evolutive features of patients with the Zollinger-Ellison syndrome combined with type I multiple endocrine neoplasia.

Ruszniewski P, Podevin P, Cadiot G, Marmuse JP, Mignon M, Vissuzaine C, Bonfils S, Lehy T. Ruszniewski P, et al. Pancreas. 1993 May;8(3):295-304. doi: 10.1097/00006676-199305000-00003. Pancreas. 1993. PMID: 8097874

6

Gastric endocrine cell evolution in patients with Zollinger-Ellison syndrome. Influence of gastrinoma growth and long-term omeprazole treatment.

Cadiot G, Lehy T, Ruszniewski P, Bonfils S, Mignon M. Cadiot G, et al. Among authors: ruszniewski p. Dig Dis Sci. 1993 Jul;38(7):1307-17. doi: 10.1007/BF01296083. Dig Dis Sci. 1993. PMID: 8100759

7

Current approach to the management of gastrinoma and insulinoma in adults with multiple endocrine neoplasia type I.

Mignon M, Ruszniewski P, Podevin P, Sabbagh L, Cadiot G, Rigaud D, Bonfils S. Mignon M, et al. Among authors: ruszniewski p. World J Surg. 1993 Jul-Aug;17(4):489-97. doi: 10.1007/BF01655108. World J Surg. 1993. PMID: 8103251 Review.

8

Long-term treatment with octreotide in patients with the Zollinger-Ellison syndrome.

Ruszniewski P, Ramdani A, Cadiot G, Lehy T, Mignon M, Bonfils S. Ruszniewski P, et al. Eur J Clin Invest. 1993 May;23(5):296-301. doi: 10.1111/j.1365-2362.1993.tb00777.x. Eur J Clin Invest. 1993. PMID: 8354336

9

Chronic endogenous hypergastrinemia in humans: evidence for a mitogenic effect on the colonic mucosa.

Sobhani I, Lehy T, Laurent-Puig P, Cadiot G, Ruszniewski P, Mignon M. Sobhani I, et al. Among authors: ruszniewski p. Gastroenterology. 1993 Jul;105(1):22-30. doi: 10.1016/0016-5085(93)90006-x. Gastroenterology. 1993. PMID: 8514038

10

Preoperative detection of duodenal gastrinomas and peripancreatic lymph nodes by somatostatin receptor scintigraphy. Groupe D'etude Du Syndrome De Zollinger-Ellison.

Cadiot G, Lebtahi R, Sarda L, Bonnaud G, Marmuse JP, Vissuzaine C, Ruszniewski P, Le Guludec D, Mignon M. Cadiot G, et al. Among authors: ruszniewski p. Gastroenterology. 1996 Oct;111(4):845-54. doi: 10.1016/s0016-5085(96)70052-5. Gastroenterology. 1996. PMID: 8831579 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

500 results

Search Page